Elevated Serum or Plasma Potassium
An artifactually high value can occur with hemolysis of red blood cells (RBCs) during venipuncture, especially if there is prolonged tourniquet use and fist clenching during the drawing of the blood or at any time prior to potassium measurement.
An artifactually high potassium value can also occur when there are greater than 1,000,000 /µL platelets or greater than 100,000/µL white blood cells (WBCs).
Renal failure from any cause, with oliguria, or as chronic nonoliguric renal failure.
Excess potassium supplements, potassium-rich foods, salt substitutes, intravenous (IV) potassium, or infusion of potassium-containing drugs, such as potassium penicillin.
Hypoaldosteronism from Addison's disease or hypofunction of the renin-angiotensin-aldosterone system.
Acute acidosis from diabetic ketoacidosis or from lactic acidosis as found with extensive crush injury, burns, or tissue necrosis.
Ingestion of drugs that inhibit potassium secretion by the kidney.
All of these situations are especially dangerous if the potassium becomes extremely elevated.
Values greater than 7.5 mEq/L are associated with serious cardiac conduction abnormalities.
Commonly Encountered Situations
Hyperkalemia is found frequently in renal failure.
The most common cause of an artifactually elevated potassium is hemolysis of RBCs.
Suggested Additional Lab Testing
Determine whether the serum or plasma showed evidence of hemolysis by a change in color from yellow to pink or red.
Complete blood count (CBC) to assess platelet count and WBC count.
Evidence of renal disease from an elevated creatinine or blood urea nitrogen (BUN), or decreased urine output.
Serum aldosterone to assess for hypoaldosteronism.
Blood gases to evaluate possible acidosis.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
- Urine Drug Testing Policy Can Assist Opioid Treatment Decisions
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|